Gene Expression Analyses of Subchondral Bone in Early Experimental Osteoarthritis by Microarray
Open Access
- 27 February 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2), e32356
- https://doi.org/10.1371/journal.pone.0032356
Abstract
Osteoarthritis (OA) is a degenerative joint disease that affects both cartilage and bone. A better understanding of the early molecular changes in subchondral bone may help elucidate the pathogenesis of OA. We used microarray technology to investigate the time course of molecular changes in the subchondral bone in the early stages of experimental osteoarthritis in a rat model. We identified 2,234 differentially expressed (DE) genes at 1 week, 1,944 at 2 weeks and 1,517 at 4 weeks post-surgery. Further analyses of the dysregulated genes indicated that the events underlying subchondral bone remodeling occurred sequentially and in a time-dependent manner at the gene expression level. Some of the identified dysregulated genes that were identified have suspected roles in bone development or remodeling; these genes include Alp, Igf1, Tgf β1, Postn, Mmp3, Tnfsf11, Acp5, Bmp5, Aspn and Ihh. The differences in the expression of these genes were confirmed by real-time PCR, and the results indicated that our microarray data accurately reflected gene expression patterns characteristic of early OA. To validate the results of our microarray analysis at the protein level, immunohistochemistry staining was used to investigate the expression of Mmp3 and Aspn protein in tissue sections. These analyses indicate that Mmp3 protein expression completely matched the results of both the microarray and real-time PCR analyses; however, Aspn protein expression was not observed to differ at any time. In summary, our study demonstrated a simple method of separation of subchondral bone sample from the knee joint of rat, which can effectively avoid bone RNA degradation. These findings also revealed the gene expression profiles of subchondral bone in the rat OA model at multiple time points post-surgery and identified important DE genes with known or suspected roles in bone development or remodeling. These genes may be novel diagnostic markers or therapeutic targets for OA.This publication has 82 references indexed in Scilit:
- Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritisBiochemical and Biophysical Research Communications, 2011
- Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritisLife Sciences, 2011
- A Novel Role of Periostin in Postnatal Tooth Formation and MineralizationPublished by Elsevier BV ,2011
- Anticytokine Therapy for OsteoarthritisDrugs & Aging, 2010
- BMP‐5 expression increases during chondrocyte differentiation in vivo and in vitro and promotes proliferation and cartilage matrix synthesis in primary chondrocyte culturesJournal of Cellular Physiology, 2007
- Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signallingArthritis Research & Therapy, 2007
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- BMP Receptor Signaling Is Required for Postnatal Maintenance of Articular CartilagePLoS Biology, 2004
- Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse boneCell and tissue research, 2000
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992